Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12032150rdf:typepubmed:Citationlld:pubmed
pubmed-article:12032150lifeskim:mentionsumls-concept:C0227525lld:lifeskim
pubmed-article:12032150lifeskim:mentionsumls-concept:C0007608lld:lifeskim
pubmed-article:12032150lifeskim:mentionsumls-concept:C0521447lld:lifeskim
pubmed-article:12032150lifeskim:mentionsumls-concept:C0600388lld:lifeskim
pubmed-article:12032150lifeskim:mentionsumls-concept:C0333117lld:lifeskim
pubmed-article:12032150lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:12032150lifeskim:mentionsumls-concept:C0439590lld:lifeskim
pubmed-article:12032150lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:12032150lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:12032150lifeskim:mentionsumls-concept:C1556066lld:lifeskim
pubmed-article:12032150lifeskim:mentionsumls-concept:C1619636lld:lifeskim
pubmed-article:12032150lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:12032150pubmed:issue31lld:pubmed
pubmed-article:12032150pubmed:dateCreated2002-7-29lld:pubmed
pubmed-article:12032150pubmed:abstractTextWe examined the signaling pathway by which hepatocyte growth factor (HGF) induces cell motility, with special focus on the role of extracellular signal-regulated kinase (ERK) in the nucleus. We used Madin-Darby canine kidney cells overexpressing ERK2 because of their prominent motility response to HGF. HGF stimulation of the cells induces not only a rapid, marked, and sustained activation and rapid nuclear accumulation of ERK1/2, but also a prolonged nuclear retention of the activated ERK1/2. Interruption of the ERK1/2 activation by PD98059 treatment of the cells 30 min after HGF stimulation abolishes the HGF-induced cell motility. Enforced cytoplasmic retention of the activated ERK1/2 by the expression of an inactive form of MKP-3 cytoplasmic phosphatase inhibits the cell motility response. Although epidermal growth factor stimulation of the cells induces the activation and nuclear accumulation of ERK1/2, it does not induce the prolonged nuclear retention of the activated ERK1/2, and fails to induce cell motility. In the nucleus, activated ERK1/2 continuously phosphorylate Elk-1, leading to the prolonged expression of c-fos, which results in the expression of several genes such as matrix metalloproteinase (mmp)-9; MMP-9 activity is required for the induction of the cell motility response. Our results indicate that the sustained activity of ERK1/2 in the nucleus is required for the induction of HGF-induced cell motility.lld:pubmed
pubmed-article:12032150pubmed:languageenglld:pubmed
pubmed-article:12032150pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:citationSubsetIMlld:pubmed
pubmed-article:12032150pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032150pubmed:statusMEDLINElld:pubmed
pubmed-article:12032150pubmed:monthAuglld:pubmed
pubmed-article:12032150pubmed:issn0021-9258lld:pubmed
pubmed-article:12032150pubmed:authorpubmed-author:TsujimotoMasa...lld:pubmed
pubmed-article:12032150pubmed:authorpubmed-author:KondoTakahito...lld:pubmed
pubmed-article:12032150pubmed:authorpubmed-author:TanimuraSusum...lld:pubmed
pubmed-article:12032150pubmed:authorpubmed-author:NomuraKayoKlld:pubmed
pubmed-article:12032150pubmed:authorpubmed-author:OzakiKei-ichi...lld:pubmed
pubmed-article:12032150pubmed:authorpubmed-author:KohnoMichiaki...lld:pubmed
pubmed-article:12032150pubmed:issnTypePrintlld:pubmed
pubmed-article:12032150pubmed:day2lld:pubmed
pubmed-article:12032150pubmed:volume277lld:pubmed
pubmed-article:12032150pubmed:ownerNLMlld:pubmed
pubmed-article:12032150pubmed:authorsCompleteYlld:pubmed
pubmed-article:12032150pubmed:pagination28256-64lld:pubmed
pubmed-article:12032150pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:meshHeadingpubmed-meshheading:12032150...lld:pubmed
pubmed-article:12032150pubmed:year2002lld:pubmed
pubmed-article:12032150pubmed:articleTitleProlonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility.lld:pubmed
pubmed-article:12032150pubmed:affiliationLaboratory of Cell Regulation, Department of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-14, Bunkyo-machi, Nagasaki 852-8521, Japan.lld:pubmed
pubmed-article:12032150pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12032150pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12032150lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12032150lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12032150lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12032150lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12032150lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12032150lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12032150lld:pubmed